Left-side vs. right-side hepatectomy for hilar cholangiocarcinoma: a meta-analysis
- PMID: 33838682
- PMCID: PMC8037893
- DOI: 10.1186/s12957-021-02213-6
Left-side vs. right-side hepatectomy for hilar cholangiocarcinoma: a meta-analysis
Abstract
Goals: We aim to draw a conclusion which type of hepatectomy could be the priority for hilar cholangiocarcinoma patients.
Background: Surgery is established as only potentially curative treatment for hilar cholangiocarcinoma. However, whether hepatectomy should be preferred to the left-side hepatectomy, which includes left hemihepatectomy, extended left hemihepatectomy, and left trisectionectomy, or right-side hepatectomy, which represents right hemihepatectomy, extended right hemihepatectomy, and right trisectionectomy, is debated. In this meta-analysis, we evaluated and compared the efficacy and safety of left-side hepatectomy and right-side hepatectomy in patients with hilar cholangiocarcinoma.
Study: We systematically retrieved the MEDLINE, PubMed, and Cochrane library and related bibliography up to February 2020. The primary outcome is overall survival, and the secondary outcome includes 1-, 3-, and 5-year survival rates, morbidity, mortality, R0 resection rate, and operation time. Based on heterogeneity, fixed-effects model or random-effects models were established through meta-analysis.
Results: Eleven studies (11 cohort studies, totally 1031 patients) were involved in this study. The overall survival of patients who underwent left-side hepatectomy was comparable to that of patients who underwent right-side hepatectomy (hazard ratio, 1.27 [95% confidence interval, 0.98-1.63]). And there was no significant difference observed in 1-year (relative risk, 1.01 [95% CI, 0.89-1.15]), 3-year (relative risk, 0.94 [95% confidence interval, 0.80-1.11]), and 5-year survival (relative risk, 0.82 [95% confidence interval, 0.67-1.01]) rates between the left-side hepatectomy group and the right-side hepatectomy group. Comparing with the right-side hepatectomy cluster, the hilar cholangiocarcinoma patients in the left-side hepatectomy cluster presented better overall postoperative morbidity (relative risk, 0.82 [95% confidence interval, 0.71-0.96]) and major postoperative morbidity (relative risk, 0.73 [95% confidence interval, 0.56-0.95]). The post-hepatectomy liver failure rate (relative risk, 0.22 [95% confidence interval, 0.09-0.56]) and procedure-related mortality (relative risk, 0.41 [95% confidence interval, 0.23-0.70]) in the left-side hepatectomy group were better than those of the right-side hepatectomy group. Besides, the R0 resection rate was similar between the left-side hepatectomy group and the right-side hepatectomy group (relative risk, 0.95 [95% confidence interval, 0.87-1.03]). And the operation time for the left-side hepatectomy was significantly longer than that for the right-side hepatectomy (mean difference, 38.68 [95% confidence interval, 7.41-69.95]).
Conclusion: Through meta-analysis, we explored the comparable long-term outcomes and better short-term outcomes in the left-side hepatectomy group as is compared to the right-side hepatectomy group of hilar cholangiocarcinoma patients. In this study, the evidence obtained might indicate that the choice of left-side hepatectomy or right-side hepatectomy depends on the site of hilar cholangiocarcinoma in every patient.
Keywords: Hilar cholangiocarcinoma; Left-side hepatectomy; Meta-analysis; Perihilar cholangiocarcinoma; Right-side hepatectomy.
Conflict of interest statement
All authors have completed the ICMJE uniform disclosure form. The authors declare that they have no competing interest.
Figures







Similar articles
-
Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience.J Hepatobiliary Pancreat Sci. 2010 Jul;17(4):476-89. doi: 10.1007/s00534-009-0204-5. Epub 2009 Oct 23. J Hepatobiliary Pancreat Sci. 2010. PMID: 19851704
-
Robotic Right Hepatectomy with En Bloc Caudatectomy for Bismuth IIIa Hilar Cholangiocarcinoma: A Video Demonstration of Left-Liver-First Anterior Radical Modular Orthotopic Right Hemihepatectomy.Ann Surg Oncol. 2024 Sep;31(9):5636-5637. doi: 10.1245/s10434-024-15407-5. Epub 2024 May 16. Ann Surg Oncol. 2024. PMID: 38755338
-
Right-side versus left-side hepatectomy for the treatment of hilar cholangiocarcinoma: a comparative study.World J Surg Oncol. 2020 Jan 4;18(1):3. doi: 10.1186/s12957-019-1779-1. World J Surg Oncol. 2020. PMID: 31901228 Free PMC article.
-
Left hepatectomy or left trisectionectomy with resection of the caudate lobe and extrahepatic bile duct for hilar cholangiocarcinoma (with video).J Hepatobiliary Pancreat Sci. 2012 May;19(3):195-202. doi: 10.1007/s00534-011-0474-6. J Hepatobiliary Pancreat Sci. 2012. PMID: 22076670 Review.
-
[Radical surgery for hilar cholangiocarcinoma (Klatskin tumor)].Cir Esp. 2007 Jul;82(1):11-5. doi: 10.1016/s0009-739x(07)71654-8. Cir Esp. 2007. PMID: 17580025 Review. Spanish.
Cited by
-
Volumetric Remodeling of the Left Liver After Right Hepatectomy: Analysis of Factors Predicting Degree of Hypertrophy and Post-hepatectomy Liver Failure.J Gastrointest Surg. 2023 Dec;27(12):2752-2762. doi: 10.1007/s11605-023-05804-8. Epub 2023 Oct 26. J Gastrointest Surg. 2023. PMID: 37884754
-
Parenchyma-Preserving Hepatectomy in Perihilar Cholangiocarcinoma: A Chance for Critical Patients?Visc Med. 2024 Apr;40(2):53-60. doi: 10.1159/000537884. Epub 2024 Mar 22. Visc Med. 2024. PMID: 38584859 Free PMC article.
-
Editorial on "Short- and long-term outcomes after hemihepatectomy for perihilar cholangiocarcinoma: does left or right side matter?".Hepatobiliary Surg Nutr. 2022 Jun;11(3):470-472. doi: 10.21037/hbsn-22-144. Hepatobiliary Surg Nutr. 2022. PMID: 35693414 Free PMC article. No abstract available.
-
Fibrinogen/albumin ratio index is an independent predictor of recurrence-free survival in patients with intrahepatic cholangiocarcinoma following surgical resection.World J Surg Oncol. 2021 Jul 20;19(1):218. doi: 10.1186/s12957-021-02330-2. World J Surg Oncol. 2021. PMID: 34284775 Free PMC article.
-
National guidelines for the diagnosis and treatment of hilar cholangiocarcinoma.World J Gastroenterol. 2024 Mar 7;30(9):1018-1042. doi: 10.3748/wjg.v30.i9.1018. World J Gastroenterol. 2024. PMID: 38577184 Free PMC article. Review.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical